What we know.
Originally, the full results of the Pilar study were going to be presented at a medical convention during the 4th quarter of this year. That was subsequently changed after the results were in to publish in a major medical journal.
What we know.
The results of the preliminary study revealed zero negative events post operation.
What we know.
At a CC, Arun was questioned about the success of the full study. He responded by simply saying, do the math. The first half of the study had zero negative events, so even if the 2nd half had the normal number of events, the total number would be substantially below the norm.
At the Investor Day conference during the panel discussion, one of the doctors indicated that the pilar results could create a real dilemna for the governing bodies related to standard of care. Would they require a time consuming phase III trial if the Pilar results were outstanding. What if there were zero events totally? Given the first half results this is well within the realm of possibilty.
For myself, I am anxiously counting the days until that report is published. They have to be truly outstanding. Afterall, why else would Arun walk away from the convention presentation?
From Arun at yesterday's JP Morgan Healthcare Conference(1-14)~
The Pillar study will be published in 8 weeks, maybe less.
Also, of the company's 51 families of patents, only half have been commercialized so far...so there's still plenty of momentum for long term growth ahead.
Sentiment: Strong Buy
Agreed, looking forward to results from that study as well as 9 other studies underway - esp in endometriosis. For now, seems like we are stuck in a period of consolidating gains of last few mos, digesting the after effects of recent equity sold at $16.75, and straddling the 50-day MA - w/ no correlation with broad mkt or convincing volumes. But here's to a strong '14 and hopefully some color on taking back the other 50% of the Lifecell JV - which expires in 18 mos.
What I know, is that this freaking thing has given up every penny it gained yesterday. Was it worth more yesterday than it is today, or for some reason unknown to us, worth less today than it was yesterday. I suspect somebody, or somebody's with a motive is jerking it around. Behind bars would be a good place for them./
Add to that thought:
Q4 2012 "8 direct sales persons, 2 marketing support" (regional sales managers?)
Q1 2013 "20 direct sales persons, 8 marketing support"
Q2 2013 "22 direct sales persons, will add 5-10 per quarter with goal of 35-40 by year end"
Q3 2013 "42 direct sales persons, goal of 60 by year end"
Presentation 2 weeks ago, in conversations with participants it was overheard---"we now have 70 sales persons and will add to that by year end."
Arun is building the pipeline for what he sees just ahead. Now add to the above that he expects these sales persons to contribute $1 million plus in revenue per person 6-9 months after hire. Sounds like additional revenue from Pinpoint and Luna of $20 million/ quarter by Q3 2014. That puts the company in the $0.15 positive earnings range by my modeling. I hadn't expected them to get to that until Q2 2015. I will gladly recalibrate my model. (:-)
I know I heard/read that figure of each salesperson contributing $1 million in revenue annually about a year after hire, and you've mentioned it on here a number of times, but when I went back and tried to find that exact comment by Arun I couldn't find it.
Do you remember where it came from? I didn't see it in any of the presentation notes I made, so maybe a quarterly CC? I'm thinking it may have been 6-9 months ago that he mentioned it? I'm just trying to get a grip on future revenue. Thanks!